Rapid Commercialization
High-Value
Biomaterials
Research and Commercialization Center
Key research areas
HBRCC (MT3+) is dedicated to bridging the gap between research and production in the medical device industry, specializing in optimizing biomaterial formulas, mass production, and rapid commercialization, while also providing multidisciplinary talent training and industry-academia collaborations to enhance the competitiveness of Taiwanese biomedical industries.
Biomaterials Testing Platform
Pre-clinical Testing Platform
Medical device commercialization
Propaganda Film
Interview
High-Value Biomaterials
High-Value Biomaterials
Research and Commercialization Center
Market Triumph Multidisciplinary Technology Medical Engineering Team
The center spans multiple partner units
HBRCC will assist researchers and industries to optimize formulas and mass production of powder/granule or liquid/gel biomaterials and derive high value biomedical implants. We also offer biomaterial rapid commercialization, a one-of-a-kind service.
Partnerships
